SCHEMBL7739874

SCHEMBL7739874

CC(C)(C)C1CCCCCC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.35
CYP1A2 P05177 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
SSTR4 P31391 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
ALOX12 P18054 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
LIPA P38571 1/20 0.31
CYP2D6 P10635 1/20 0.30
KCNH2 Q12809 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738664 1.00 EPHX1 (0.48) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL93482 1.00 EPHX1 (0.48) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL7738636 1.00 EPHX1 (0.48) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL7741586 1.00 EPHX1 (0.48) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL28219573 0.97 EPHX1 (0.46) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
Fluoride SCHEMBL27373487 0.97 EPHX1 (0.46) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL6905025 0.97 EPHX1 (0.46) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
SCHEMBL23271 0.96
Methyl Alcohol SCHEMBL27768087 0.94 EPHX1 (0.50) EPHX1SMN1; SMN2CYP1A2KDM4EHTT
Cyanide SCHEMBL28137542 0.91 EPHX1 (0.43) EPHX1SMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109647199-A A kind of preparation method of reverse osmosis membrane and thus obtained reverse osmosis membrane 时代沃顿科技有限公司 2019-04-19 CN claimed
WO-2017144898-A1 WOOD PRODUCT JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2017-08-31 WO claimed
US-20230382926-A1 COMPOUNDS AND USES THEREOF THE UNIVERSITY OF THE WEST INDIES (TT) 2023-11-30 US disclosed
CN-114682102-B Reverse osmosis membrane and preparation method thereof 沃顿科技股份有限公司 2023-06-27 CN disclosed
CN-114682102-A Reverse osmosis membrane and preparation method thereof 沃顿科技股份有限公司 2022-07-01 CN disclosed
CN-112892249-A Polyamide reverse osmosis membrane and preparation method thereof 时代沃顿科技有限公司 2021-06-04 CN disclosed
CN-109647199-A A kind of preparation method of reverse osmosis membrane and thus obtained reverse osmosis membrane 时代沃顿科技有限公司 2019-04-19 CN disclosed
WO-2017144898-A1 WOOD PRODUCT JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2017-08-31 WO disclosed
EP-2765155-A1 CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME Toray Industries, Inc. (JP) 2014-08-13 EP disclosed
CN-101105630-A Radiation sensitive composition for forming a colored layer, color filter and color liquid crystal display device JSR CORP (JP) 2008-01-16 CN disclosed
US-6410748-B1 Alicycli c group-containing monomer KABUSHIKI KAISHA TOSHIBA (JP) 2002-06-25 US disclosed
US-6291129-B1 LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS KABUSHIKI KAISHA TOSHIBA (JP) 2001-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382926-A1 COMPOUNDS AND USES THEREOF CFTR, CCL11, CEL EPHX1 1379/4885SMN1; SMN2 2499/4885CYP1A2 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.